Patent Yard Sign in
Canadian application, no grantCanada

Method for diagnosing diffuse-type gastric cancer

CA 2503517 A1 · Owner: Japan As Represented By The President Of The University Of Tokyo · Inventors: Furukawa, Yoichi; Nakamura, Yusuke

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Methods for detecting and diagnosing diffuse-type gastric cancer (DGC) are described herein. In one embodiment, the diagnostic method involves the determination of an expression level of DGC -associated gene that discriminate between DGC and normal cell. The present invention further provides methods of screening for therapeutic agents useful in the treatment of DGC methods of , treating DGC and method of vaccinating a subject against DGC.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 19, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 19, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 19, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 19, 2003
GrantedNo grant recorded
Term endedSeptember 19, 2023
Patent numberCA 2503517 A1
Classification (IPC)C12Q1/68

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedSep 19, 2003Term endedSep 19, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.